Showing 81 - 100 results of 30,445 for search '(( 03 1 decrease ) OR ( 50 ((((ns decrease) OR (nn decrease))) OR (we decrease)) ))', query time: 0.63s Refine Results
  1. 81
  2. 82
  3. 83

    DataSheet2_Decreasing incidence and mortality of lung cancer in Hungary between 2011 and 2021 revealed by robust estimates reconciling multiple data sources.xlsx by Gabriella Gálffy (177759)

    Published 2024
    “…The COVID-19 pandemic resulted in a statistically significant decrease in lung cancer incidence, especially in the 50–59 age group (both sexes).…”
  4. 84
  5. 85
  6. 86

    Preclinical Evaluation of <sup>131</sup>I/<sup>18</sup>F‑Labeled Covalent Small-Molecule Inhibitors for STING Status Imaging by Jianyang Fang (11301298)

    Published 2024
    “…This ratio significantly decreased in the blocking group (1.10 ± 0.14, **<i>P</i> < 0.01, <i>n</i> = 3). …”
  7. 87

    Preclinical Evaluation of <sup>131</sup>I/<sup>18</sup>F‑Labeled Covalent Small-Molecule Inhibitors for STING Status Imaging by Jianyang Fang (11301298)

    Published 2024
    “…This ratio significantly decreased in the blocking group (1.10 ± 0.14, **<i>P</i> < 0.01, <i>n</i> = 3). …”
  8. 88

    Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

    Published 2022
    “…Here, we synthesized a newseries of <i>mono</i>- and <i>bis</i>(dimethylpyrazolyl)-<i>s</i>-triazine derivatives. …”
  9. 89
  10. 90
  11. 91
  12. 92
  13. 93
  14. 94

    Image_1_IL-12p40/IL-23p40 Blockade With Ustekinumab Decreases the Synovial Inflammatory Infiltrate Through Modulation of Multiple Signaling Pathways Including MAPK-ERK and Wnt.TIF by Renée H. Fiechter (10230473)

    Published 2021
    “…No serious adverse events occurred. We observed numerical decreases of all infiltrating cell subtypes at week 12, reaching statistical significance for CD68+ sublining macrophages. …”
  15. 95
  16. 96
  17. 97
  18. 98
  19. 99
  20. 100